Prognostic significance of CEBPA mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: A study of the AML study group Ulm.

被引：0
|
作者：
Frohling, S [1 ]
Schlenk, RF [1 ]
Stolze, I [1 ]
Bihlmayr, J [1 ]
Kreitmeier, S [1 ]
Tobis, K [1 ]
Dohner, H [1 ]
Dohner, K [1 ]
机构：
[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2962
引用
收藏
页码：748A / 748A
页数：1
相关论文
共 50 条
  • [31] Prognostic Significance of DNA Methyltransferase 3A Mutations in Cytogenetically Normal Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association
    Renneville, Aline
    Boissel, Nicolas
    Nibourel, Olivier
    Berthon, Celine
    Helevaut, Nathalie
    Gardin, Claude
    Cayuela, Jean-Michel
    Hayette, Sandrine
    Reman, Oumedaly
    Contentin, Nathalie
    Bordessoule, Dominique
    Pautas, Cecile
    de Botton, Stephane
    De Revel, Thierry
    Terre, Christine
    Fenaux, Pierre
    Thomas, Xavier
    Castaigne, Sylvie
    Dombret, Herve
    Preudhomme, Claude
    BLOOD, 2011, 118 (21) : 1072 - 1073
  • [32] Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
    Renneville, A.
    Boissel, N.
    Nibourel, O.
    Berthon, C.
    Helevaut, N.
    Gardin, C.
    Cayuela, J-M
    Hayette, S.
    Reman, O.
    Contentin, N.
    Bordessoule, D.
    Pautas, C.
    de Botton, S.
    de Revel, T.
    Terre, C.
    Fenaux, P.
    Thomas, X.
    Castaigne, S.
    Dombret, H.
    Preudhomme, C.
    LEUKEMIA, 2012, 26 (06) : 1247 - 1254
  • [33] Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
    A Renneville
    N Boissel
    O Nibourel
    C Berthon
    N Helevaut
    C Gardin
    J-M Cayuela
    S Hayette
    O Reman
    N Contentin
    D Bordessoule
    C Pautas
    S de Botton
    T de Revel
    C Terre
    P Fenaux
    X Thomas
    S Castaigne
    H Dombret
    C Preudhomme
    Leukemia, 2012, 26 : 1247 - 1254
  • [34] Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype:: A cancer and leukemia group B study
    Farag, SS
    Ruppert, AS
    Mrózek, K
    Mayer, RJ
    Stone, RM
    Carroll, AJ
    Powell, BL
    Moore, JO
    Pettenati, MJ
    Koduru, PRK
    Stamberg, J
    Baer, MR
    Block, AW
    Vardiman, JW
    Kolitz, JE
    Schiffer, CA
    Larson, RA
    Bloomfield, CD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 482 - 493
  • [35] ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group
    Paschka, Peter
    Schlenk, Richard F.
    Gaidzik, Verena I.
    Herzig, Julia K.
    Aulitzky, Teresa
    Bullinger, Lars
    Spaeth, Daniela
    Teleanu, Veronika
    Kuendgen, Andrea
    Koehne, Claus-Henning
    Brossart, Peter
    Held, Gerhard
    Horst, Heinz-A.
    Ringhoffer, Mark
    Goetze, Katharina
    Nachbaur, David
    Kindler, Thomas
    Heuser, Michael
    Thol, Felicitas
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    HAEMATOLOGICA, 2015, 100 (03) : 324 - 330
  • [36] Screening for partial tandem duplications (PTD) of the MLL gene in elderly patients (> 60 years) with acute myeloid leukemia:: A study within the multicenter treatment trial AML HD98-B of the AML study group Ulm (AMLSG ULM).
    Tobis, K
    Schlenk, RF
    Hein, S
    Frohling, S
    Dohner, H
    Dohner, K
    BLOOD, 2002, 100 (11) : 240B - 240B
  • [37] Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)-An International Study
    Wetzler, Meir
    Kohlschmidt, Jessica
    Mrozek, Krzysztof
    Dombret, Herve
    Doehner, Hartmut
    Pilorge, Sylvain
    Krug, Utz
    Larson, Richard A.
    Marcucci, Guido
    Hiddemann, Wolfgang
    Buchner, Thomas
    Bloomfield, Clara D.
    BLOOD, 2011, 118 (21) : 1080 - 1081
  • [38] PROGNOSTIC IMPACT OF WT1 MUTATIONS IN THE CONTEXT OF OTHER MOLECULAR MARKERS IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (AML): A STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
    Gaidzik, V. I.
    Moschny, S.
    Becker, A.
    Groner, S.
    Spaeth, D.
    Krauter, J.
    Schlegelberger, B.
    Ganser, A.
    Doehner, H.
    Schlenk, R. F.
    Doehner, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 375 - 375
  • [39] Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
    Gaidzik, Verena I.
    Schlenk, Richard F.
    Paschka, Peter
    Stoelzle, Anja
    Spaeth, Daniela
    Kuendgen, Andrea
    von Lilienfeld-Toal, Marie
    Brugger, Wolfram
    Derigs, Hans Guenter
    Kremers, Stephan
    Greil, Richard
    Raghavachar, Aruna
    Ringhoffer, Mark
    Salih, Helmut R.
    Wattad, Mohammed
    Kirchen, Heinz G.
    Runde, Volker
    Heil, Gerhard
    Petzer, Andreas L.
    Girschikofsky, Michael
    Heuser, Michael
    Kayser, Sabine
    Goehring, Gudrun
    Teleanu, Maria-Veronica
    Schlegelberger, Brigitte
    Ganser, Arnold
    Krauter, Juergen
    Bullinger, Lars
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2013, 121 (23) : 4769 - 4777
  • [40] Independent validation of prognostic relevance of a previously reported gene-expression signature in acute myeloid leukemia (AML) with normal cytogenetics (NC):: A cancer and leukemia group B (CALGB) study.
    Marcucci, G
    Radmacher, MD
    Ruppert, AS
    Mrózek, K
    Kolitz, JE
    Whitman, SP
    Edwards, CG
    Vardiman, JW
    Caligiuri, MA
    Carroll, AJ
    Larson, RA
    Bloomfield, CD
    BLOOD, 2005, 106 (11) : 223A - 223A
12345